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MAJOR ARTICLE

Lack of Awareness of Human Immunodeﬁciency
Virus (HIV) Infection: Problems and Solutions
With Self-reported HIV Serostatus of Men Who
Have Sex With Men
Travis H. Sanchez,1 Colleen F. Kelley,1,2 Eli Rosenberg,1 Nicole Luisi,1 Brandon O’Hara,1 Rodriques Lambert,3
Raphael Coleman,1 Paula Frew,1,2 Laura F. Salazar,4 Sijia Tao,5 William Clarke,6 Carlos del Rio,1 and Patrick S. Sullivan1
1

Rollins School of Public Health, Emory University and Emory Center for AIDS Research, 2Division of Infectious Disease, Department of Medicine, Emory
University School of Medicine, 3HIV/AIDS Epidemiology, Georgia Department of Public Health, 4School of Public Health, Georgia State University, and
5
Laboratory of Biochemical Pharmacology, Emory University, Atlanta, Georgia; and 6School of Medicine, Johns Hopkins University, Baltimore, Maryland

Background. Lack of human immunodeﬁciency virus (HIV) infection awareness may be a driver of racial disparities in HIV infection among men who have sex with men (MSM). Lack of awareness is typically measured by comparing
HIV test result to self-reported HIV status. This measure may be subject to reporting bias and alternatives are needed.
Methods. The InvolveMENt study examined HIV disparities between black and white MSM from Atlanta. Among
HIV-positive participants who did not report knowing they were positive, we examined other measures of awareness:
HIV viral load (VL) <1000 copies/mL (low VL), antiretroviral (ARV) drugs in blood, and previous HIV case surveillance
report.
Results. Using self-report only, 32% (62 of 192) of black and 16% (7 of 45) of white MSM were not aware of their
HIV infection (P = .03). Using self-report and low VL, 25% (48 of 192) black and 16% (7 of 45) white MSM lacked
awareness (P = .18). Using self-report and ARVs, 26% (50 of 192) black and 16% (7 of 45) white MSM lacked awareness
(P = .14). Using self-report and surveillance report, 15% (28 of 192) black and 13% (6 of 45) white MSM lacked awareness (P = .83).
Conclusions. Self-report only may overestimate true lack of awareness of HIV status for black MSM. If, as our data
suggest, black MSM are not less likely to be aware of their HIV infection than are white MSM, then this factor is not a
substantial driver of HIV disparity. Future HIV research that depends on accurate measurement of HIV status awareness
should consider including additional laboratory and case surveillance data.
Keywords. HIV; MSM; survey; testing.

Over the past decade, men who have sex with men
(MSM) have been the only group in the United States
in which human immunodeﬁciency virus (HIV)
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incidence has increased [1]. More recently, increases
in incidence have been concentrated among young
MSM of color [2]. Black MSM have over twice the prevalence of HIV than white men, [3, 4] and data from the
HIV Prevention Trials Network study number 061 suggest that black MSM experience an HIV incidence rate
over 5 times that of white MSM [5]. The reasons for
these racial disparities in HIV infection among MSM
are unclear, but differences in individual-level risk behaviors likely do not account for the observed disparities [4, 6]. This same pattern of disparity exists among
black MSM in Atlanta, the city with the 8th highest
rate of new HIV diagnoses and 4th highest number of
new HIV diagnoses among MSM in the country in 2011
[7]. Men who have sex with men comprise the largest
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group living with HIV in Atlanta, and black MSM are disproportionately affected, constituting approximately 60% of
HIV-infected MSM, whereas black persons represent only approximately 30% of the overall Atlanta population [8].
Differences in awareness of HIV infection between black and
white MSM are hypothesized to contribute to this disparity [6].
Overall, approximately 20% of persons infected with HIV in the
United States are thought to be unaware of their infection; however, they account for an estimated 49% of transmission events
[9]. Awareness of HIV infection results in a reduction in highrisk sexual behavior [10], and it is the ﬁrst critical step in the
continuum of HIV care, which ideally results in receipt of antiretroviral (ARV) therapy, achievement of an undetectable HIV
viral load (VL), and reduction in HIV transmissions [11–13].
National surveillance data show that black MSM have high levels (59%) of lack of awareness of HIV infection compared with
white MSM (26%) [14].
HIV surveillance projects and research studies use a similar
set of testing history questions to deﬁne self-reported lack of
awareness of infection that is detected through study-delivered
testing. However, there are new reports that the validity of this
self-reported measure may be questionable for some groups of
MSM [5, 15, 16]. It remains unknown whether the validity of
these measures may differ by participant race and whether viable solutions to improve the measure may be available to HIV
researchers. For this study, we hypothesized that the combination of traditional survey, laboratory, and public health surveillance data could improve the measurement of awareness of HIV
infection among black and white MSM participants of a
research study in Atlanta, Georgia.
METHODS
InvolveMENt Study

The InvolveMENt study was a prospective cohort study designed to examine factors that may contribute to disparities in
HIV and sexually transmitted infection between black and
white MSM in Atlanta. MSM aged 18–39 years were recruited,
regardless of HIV status, primarily using time-space venue sampling, with a sampling frame built upon that used for the Atlanta site for the second MSM cycle of the National HIV
Behavioral Surveillance System (NHBS-MSM) [17, 18]. Facebook was also included as a virtual venue. The InvolveMENt
study methods have been previously reported but are brieﬂy
described here [19]. Eligible participants were self-identiﬁed
black and white MSM who reported sex with another man
in the previous 3 months, who were not in a mutually monogamous relationship, could complete survey instruments in
English, lived in the Atlanta metropolitan area, were not enrolled in another HIV prevention study, who did not identify
as Hispanic/Latino, and had no plans to relocate in the subsequent 2 years. During the baseline visit consent process,
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participants were informed that they would be screened for
HIV infection, but the criteria for which participants would
be offered enrollment in the prospective component of the
study were not speciﬁcally discussed.
All InvolveMENt study participants were tested for HIV
using a rapid test with conﬁrmation by enzyme-linked immunosorbent assay and Western blot analysis. Before results of
HIV testing were returned, participants completed a detailed
computer-assisted self-interview. All HIV-positive men had
HIV VL testing (COBAS AmpliPrep/COBAS TaqMan HIV-1
test kit version 2.0; Roche Molecular Systems, Inc.), and these
results were returned to participants. Participants who had a
negative HIV rapid test at baseline were offered enrollment in
the follow-up study. If a participant subsequently tested HIV
positive at the 3-month visit, we conducted VL testing on the
stored specimen from the baseline visit. Those who had detectable VL (but who were nonreactive on the HIV rapid test) were
considered to have acute HIV infection at the time of their baseline visit. The InvolveMENt study staff (eg, counselors, phlebotomists, interviewers) were diverse in regards to race, ethnicity,
age, and gender. The InvolveMENt study was reviewed and approved by the institutional review board of Emory University.
Measures

We used several approaches to classify HIV infection awareness.
The ﬁrst method (“self-reported”) deﬁned awareness of infection using a set of questions about their experiences ever getting
tested, the most recent testing experiences, and their most recent test result. In addition, during the posttest result discussion, any participant who disclosed prior knowledge of their
HIV status to the study counselor was classiﬁed as “self-reported
aware,” even if they did not report having a previous HIV-positive
test in their survey.
Among those who were classiﬁed as not aware of their HIV
infection by self-report, we also explored 2 laboratory measures
and a public health surveillance measure of awareness. One laboratory measure was low VL (<1000 copies/mL or undetectable)
on the baseline blood specimen. The other laboratory measure
was detectable ARV drugs using either of 2 nonmutually exclusive algorithms. First, for those MSM classiﬁed as not aware of
their HIV infection by self-report and who also had a low VL, we
conducted a limited quantiﬁcation ARV panel that included
commonly prescribed nucleoside/nucleotide reverse-transcriptase inhibitors ([NRTIs] abacavir, emtricitabine, lamivudine, tenofovir, and zidovudine) [20]. This limited quantiﬁcation ARV
panel was the ﬁrst we explored and was not done on all specimens
because of the potential expense involved. Second, for all MSM
classiﬁed as not aware by self-report, we used mass spectrometry to test an expanded ARV panel that included NRTIs (emtricitabine, lamivudine, tenofovir, and zidovudine), nonnucleotide
reverse-transcriptase inhibitors (efavirenz and nevirapine), and
protease inhibitors (atazanavir, darunavir, fosamprenavir,

indinavir, lopinavir, nelﬁnavir, ritonavir, saquinavir, and tipranavir) [16]. The results of the ARV testing were not returned to
participants.
For the public health surveillance measure of awareness, we
used evidence of a preexisting HIV case surveillance report at
the Georgia Department of Public Health. We submitted to
the state health department a line-listing of black and white participants considered not aware of their status by self-report. The
health department reported back on the total number of persons from the list who were already in the HIV case surveillance
system and whose ﬁrst HIV diagnosis in the system had occurred at least 21 days before our diagnosis. This timeframe
was selected to ensure that persons who were previously diagnosed more recently would have had at least some opportunity
to receive their previous test result. To protect conﬁdentiality of
case surveillance data, the health department did not return a
list of persons with previous diagnoses to the study’s researchers, but it only provided us with aggregate numbers. The health
department also reported the mean number of days between the
ﬁrst HIV diagnosis in the system and our diagnosis.
Participants who enrolled through February 2012 and were
not aware of their HIV infection by self-report were also invited
to participate in an in-depth interview. A staff interviewer conducted one-on-one discussions with participants at a follow-up
visit to the study ofﬁce (ie, the qualitative interviews happened
after the visit in which they tested HIV-positive). The interviewer used a semistructured qualitative interview method with a set
of open-ended question domains with follow-up probes. The
purpose of the interviews was to generate more detailed information about previous HIV testing experiences and diagnoses,
general themes regarding disclosure of HIV status, and rephrasing activities to better understand comprehension of the HIV
testing questions. Participants were not speciﬁcally asked
about possible discrepancies between self-reported awareness
and laboratory testing.
Analyses

We compared lack of awareness of HIV infection between black
and white MSM using χ2 tests for the different measures: selfreport alone, self-report plus low VL, self-report plus detectable
ARV, and self-report plus previous HIV case surveillance report. Findings were considered signiﬁcant if P < .05. Statistical
analyses were performed using OpenEpi (www.OpenEpi.com,
version 2013/04/06).
RESULTS
Enrollment occurred from July 2010 through December 2012, resulting in a total of 454 black MSM and 349 white MSM being
enrolled and contributing to this analysis. The prevalence of HIV
infection at the baseline visit among black MSM was 43% (197
of 454), compared with 13% (46 of 349) among white MSM

Table 1. Characteristics of MSM Classiﬁed as Lacking Awareness
of Their HIV Infection, InvolveMENt Study, 2010–2012
Black MSM
(N = 62)

No.

(%)

No.

(%)

Never Tested

14

(23)

1

(14)

Ever Tested, Last Result
Negative

39

(63)

6

(86)

3

(5)

0

(0)

6
14

(10)
(23)

0
0

(0)
(0)

HIV Testing History Questions

Indeterminate
Didn’t Get It
HIV Viral Load <1000 copies/mL
Any Antiretroviral Drug Detected
Mass Spectrometry
NRTI Quantificationa
Previously Reported to HIV Case
Surveillanceb

12

(19)

0

(0)

12
7

(19)
(11)

0
0

(0)
(0)

34

(55)

1

(14)

Abbreviations: HIV, human immunodeficiency virus; MSM, men who have sex
with men; NRTI, nucleoside/tide reverse-transcriptase inhibitor.
a

NRTI blood levels only performed among those with HIV viral load <1000
copies/mL.

b

Average time between previous report and InvolveMENt report = 1590 days.

(prevalence ratio = 3.3; 95% conﬁdence interval = 2.5, 4.4) [19].
There were 5 black MSM and 1 white MSM who were considered
to have acute HIV infection at the time of their baseline visit and
were excluded from further analysis.
Among black MSM with HIV infection at baseline, 69 were
classiﬁed as not aware on survey responses alone, and 7 disclosed knowledge of their status during posttest counseling.
Among white MSM with HIV infection at baseline, 8 were classiﬁed as not aware by survey responses alone, and 1 disclosed
knowledge of his status during posttest counseling. The measure
of self-reported lack of awareness of HIV status was 32% (62 of
192) among black MSM and 16% (7 of 45) among white MSM.
Most participants (65%, 45 of 69) who disclosed not being
aware of their infection had been previously HIV tested and reported that their most recent test result was negative (Table 1).
Fourteen participants (14 black MSM and 0 white MSM)
who were classiﬁed as not aware by self-report had a low VL.
The limited panel of ARV testing was completed for 13 of
them; 7 of whom had at least 1 NRTI detected. The expanded
ARV panel was completed for 60 of 69 MSM (53 of 62 black
MSM and 7 of 7 white MSM); 12 of whom (all black MSM)
had ARV detected. Thirteen participants had both types of ARV
testing; 7 of whom had ARV detected on both tests, 4 had no
ARV detected on either test, and 2 had ARV on mass spectrometry that was not detected on the quantitative NRTI test (Table 2
shows detected ARV results). Two participants with high VL
(14 755 and 16 802 copies/mL) had detectable ARV, and both
had only zidovudine detected.
Lack of Awareness of HIV Infection Among MSM
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x
x

x

x

x

x

x
x

x

x
x

x

x

x

x

x

x

x
x

x
x

x

ATV
FPV

Yes
Yes
No
Yes

Yes
Not Performed

Undetectable
62
591
621

521

181

Yes
Yes
No
Yes
271
451

743
Undetectable

Yes
Yes
241

70

Yes
Yes
Yes
Yes
151
171

28
Undetectable

Yes
Not Performed
081

14755

Yes
Yes

Yes
Not Performed
162
16802
031
051

021

Undetectable

Yes
Yes

x

ABC
Participant ID

•

Abbreviations: ABC, abacavir; ARV, antiretroviral; ATV, atazanavir; DRV, darunavir; EFV, efavirenz; FPV, amprenavir; FTC, emtricitabine; IDV, indinavir; LPV, lopinavir; NFV, nelfinavir; NRTI, nucleoside/nucleotide reversetranscriptase inhibitor; NVP, nevirapine; RTV, ritonavir; SQV, saquinavir; TDF, tenofovir; TPV, tipranavir; ZDV, zidovudine; 3TC, lamivudine.

x

x

ZDV
TPV
TDF
SQV
RTV
NVP
NFV
LPV
3TC
DRV

FTC

EFV

IDV

ARV detected

Mass Spectrometry
ARV Detected
NRTI Quantification
ARV Detected
HIV Viral Load
(Copies/mL)

Table 2. Antiretroviral Drugs Detected Among Men Who Have Sex with Men Classiﬁed as Lacking Awareness of Their HIV Infection Based on Self-disclosure, InvolveMENt Study,
2010–2012
4
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Figure 1. Lack of awareness of human immunodeﬁciency virus (HIV) serostatus among black and white men who have sex with men (MSM) in the
InvolveMENt study, 2010–2012, using 3 approaches to deﬁning lack of
awareness. χ2 P values provided.

There were 35 participants (34 black MSM and 1 white
MSM) who were classiﬁed as not aware on self-report and had
a previous HIV diagnosis reported to the health department.
The mean time between the ﬁrst HIV diagnosis reported to
the health department and the InvolveMENt study baseline
visit was ∼4.4 years.
Based on self-report only, black MSM were signiﬁcantly less
likely to be aware of their HIV infection than were white MSM
(Figure 1). Based on self-report combined with any of the other
criteria, the proportions of black MSM not aware of their infection were not signiﬁcantly higher than the proportions of white
MSM not aware. Based on self-report and previous report to the
health department, the proportions of black MSM and white
MSM not aware of their infection was essentially the same
(15% and 13%, respectively).
Of the 55 participants who did not self-report awareness and
were invited to the in-depth interviews, 15 took part (13 black
MSM and 2 white MSM). Twelve participants conﬁrmed accuracy of their survey responses in regards to not being previously aware of their HIV infection, 2 of whom had detectable
ARV. Three participants identiﬁed inaccuracies in their original
survey responses: 1 reported that his most recent test was HIVnegative, but his survey response was “indeterminate”; 1 reported
that his most recent test was HIV-positive, but his survey
response was “didn’t get result of most recent test”; and 1 was
aware of his previous HIV diagnosis but had been retested and
had not gotten the result of that most recent test. There were no
issues noted in the comprehension of the HIV testing history
questions.
DISCUSSION
Up to one half of our study participants who were not considered to be aware of their positive HIV status based on

discordance between self-report and testing results may have
actually been aware of their HIV infection. During qualitative
interviewing with a subset of participants, we found some
inconsistencies between survey responses and detailed questions about HIV testing history, but there was no evidence of
systematic misinterpretation of testing questions or response
options. When we used any of the alternative methods of deﬁning awareness, the difference in awareness between black and
white MSM was no longer signiﬁcant.
Our study’s sample size did not allow us to calculate sensitivity and speciﬁcity of the laboratory measures of awareness, but
this framework may be useful to consider here. The speciﬁcity
of ARV testing is likely very high as a measure of awareness of
HIV status because there are probably few situations in which
someone not aware of their status would have detectable ARV;
one such possibility is use of HIV pre-exposure prophylaxis
(PrEP) [21]. The Centers for Disease Control and Prevention
guidance on PrEP use among MSM was released in the middle
of our study, and although we added questions about current
PrEP use in follow-up surveys, most participants were not
asked this question in their baseline survey. The sensitivity of
ARV detection as a measure of awareness is more questionable
and likely dependent on many factors, especially being engaged
in care and being adherent to an ARV regimen. The speciﬁcity
of low VL as a measure of awareness is also likely high because,
although it is possible that a person may have a low VL but not
be aware of his HIV status (eg, an “HIV controller”), this situation is probably uncommon. Although there are no populationlevel studies of VL in treatment-naive persons, there was an 8%
prevalence of VL <1000 copies/mL in reportedly treatmentnaive participants in a large combined study of multiple prospective research cohorts of patients infected with HIV [22].
The prevalence of HIV controllers (>10 years of infection duration and 90% of VL <500 copies/mL) was estimated to be 0.22%
in 1 large cohort study of persons infected with HIV in France
[23]. Our ﬁndings suggest that the sensitivity of a low VL as a
measure of awareness may be high because we found that all but
2 participants with detectable ARV had low VL. Future studies
with larger samples of HIV-positive persons should explore further the sensitivity and speciﬁcity of these 2 measures separately
and in combination.
Matching ﬁndings from research studies to HIV case surveillance reports may also be a viable means of estimating lack of
awareness of HIV infection. Veriﬁcation of whether a previous
positive HIV test result was returned to a patient is not part of
the surveillance case report. Men may have had a previous positive HIV test but not actually received the results of the test and
therefore may not have been aware of their status, although
there are factors that argue against this. Another study found
that 90% of MSM get the results of their HIV test and did
not ﬁnd any signiﬁcant racial difference in getting results
[24]. Previous behavioral surveillance data have also reported

that almost two-thirds of black MSM have had an HIV test in
the past year [25], but the average time between ﬁrst case surveillance report and our study’s diagnosis was more than 4
years. Even if our participants did not get the result of that
ﬁrst reported diagnosis, the typical frequency of HIV testing
among MSM makes it unlikely that they would have gone this
length of time without another HIV test for which they got their
test result.
It should also be noted that several participants conﬁrmed
their survey responses during the in-depth interviews, although
results of ARV testing indicated that they were taking ARVs and
therefore likely aware of their HIV status at the time of enrollment. These participants were also aware that researchers already knew of their status through the study-delivered testing.
We did not have the results of all of the ARV testing at the
time of these interviews, and participants were not speciﬁcally
asked about possible discrepancies between the different measures of awareness. Regardless, these interviews still underscore
that some part of the research process is creating an environment in which black MSM do not feel inclined to disclose
knowledge of their HIV status to researchers. This may be
due to HIV-related stigma or distrust in HIV research, both
of which have been reported among black MSM [26–28].
The signiﬁcant racial differences in self-reported awareness of
HIV infection in our study is similar to that reported by NHBSMSM [29]. The HIV testing history questions used in our study
were the same as those used in the ﬁrst cycle of NHBS-MSM,
but more recent versions of the NHBS-MSM survey include
an additional question about ever having had an HIV diagnosis.
There was no signiﬁcant change in self-reported awareness of
HIV status between the ﬁrst and second versions of the NHBSMSM survey [30]; therefore, it is also unlikely that the addition of
the more sensitive “ever positive” question would have substantially altered our ﬁndings. In addition, only 1 participant of the
in-depth interviews reported awareness of his status based on
ever having a positive HIV test result.
Human immunodeﬁciency virus case surveillance data estimates that 19.4% of MSM living with HIV infection in the United States have not yet been diagnosed [31]. Although these
surveillance estimates should not be interpreted to be equivalent
to lack of awareness of HIV status, the wide discrepancy between the most recent NHBS-MSM estimate (34%) and the surveillance-based estimate are problematic for public health [32].
Our study gives a potential explanation for this discrepancy:
that self-report alone may overestimate lack of awareness
among black MSM because of misclassiﬁcation.
There is evidence from other research that underreporting of
awareness to researchers is occurring. A recently published study
from enrollment of black MSM in a community-randomized
HIV prevention trial in 5 cities (including Atlanta) determined
that among 155 HIV-positive black MSM who said that they
were not aware of their HIV status, 54% had a VL of <1000
Lack of Awareness of HIV Infection Among MSM
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copies/mL and 78% of those had detectable ARVs [5, 16]. These
results are substantially higher than those we observed in our
Atlanta cohort of black and white MSM. That other study specifically recruited and enrolled black MSM who believed themselves
to be HIV-negative, which may have produced the discrepancy
between our ﬁndings. Underreporting of awareness by HIVpositive black MSM may also not be isolated to just the research
environment. Other studies have reported that from one third to
one half of HIV-positive black MSM do not disclose their serostatus to sexual partners [32, 33].
The current paradigm for racial disparity in HIV infection
dictates that the higher rates of HIV acquisition among black
MSM are due in part to (1) an increased likelihood for black MSM
to have black male sex partners; (2) a higher rate of HIV prevalence among black MSM; and (3) a lower awareness of HIV status
among HIV-positive black MSM [4, 6]. This third pillar of the
paradigm is based on a premise that black MSM are less likely
to be aware of their HIV status than are white MSM and are
therefore less able act on this knowledge to protect their susceptible sexual partners from exposure to HIV. At a minimum, the
magnitude of disparity in lack of awareness of HIV status for
black MSM may be overstated with the use of only self-reported
data. If, as our data suggest, black MSM are equally aware of their
HIV status compared with white MSM, then the ﬁeld would need
to reconsider this paradigm and the HIV prevention programs
upon which it is built.
Several limitations should be noted for this analysis. Our
study involved incentivized research and had relatively small
sample sizes for some groups. This not only limited our ability
to conduct more detailed statistical analysis, but it would also
limit generalizability, especially to other HIV testing programs
or surveillance activities with MSM. Although the insights
gained from the in-depth interviews were valuable and allowed
for added veriﬁcation of the quantitative ﬁndings, we also had a
limited number of these interviews, and it is likely that those
who agreed to an interview were different from those who refused, resulting in selection bias. A previous surveillance case
report does not equal a person knowing their HIV status. The
surveillance case match results were only provided on an aggregate level; therefore, we could not determine how laboratory and
surveillance case-match measures aligned for individual participants. Finally, it should be acknowledged that another jurisdiction’s public health regulations and policies may not allow for
replication of the case-match approach.
CONCLUSIONS
Gaining knowledge of one’s own HIV status will remain a cornerstone of HIV prevention, but additional research is clearly
warranted to understand the context in which black MSM do
or do not report awareness of their HIV status to researchers
or to testing program personnel. This research should involve
6
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larger studies that apply multiple measures of determining
awareness of status and that include qualitative interviews to
speciﬁcally explore situations in which there is a discrepancy
in these measures. Until a potential gold standard for awareness
of HIV status can be determined from these larger studies, future HIV research that relies on the accuracy of this indicator
should consider using multiple ways to measure it.
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